TP53 and laryngeal carcinoma: Of interest is that BCCIP loss has also been shown to abrogate p53 transcriptional activity [28], and BCCIP downregulation is associated with a poor prognosis in laryngeal cancer with wild-type p53 but not with mutant p53 [29].